Syngene International Quarterly Results for Trading Insights

SYNGENE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹67 Cr
QSept 2025
Quarterly Results

Syngene International Quarterly Results Key Highlights

  • Revenue of ₹926 Cr in Sept 2025 (-10.7% vs Mar 2025, +2.0% vs Sept 2024)
  • Net Profit of ₹67 Cr in Sept 2025 (-63.4% vs Mar 2025, -36.8% vs Sept 2024)
  • EBITDA of ₹215 Cr in Sept 2025 (-40.8% vs Mar 2025)
  • Operating Margin of 22.0% in Sept 2025 (-12.0pp vs Mar 2025)
  • Earnings Per Share of ₹1.67 in Sept 2025 (-63.4% vs Mar 2025)

Syngene International Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 926 1,037 892 933 908 -10.7% 2.0%
Net Profit (₹ Cr) 67 183 87 15 106 - -
EBITDA (₹ Cr) 215 363 224 154 261 - -
EPS (₹) 1.67 4.56 2.16 0.37 2.64 - -
Operating Margin (%) 22.0% 34.0% 24.0% 15.0% 27.0% - -

Syngene International Share Price Trend Around Quarterly Results

Visualize Syngene International's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Syngene International

Additional stock information and data for SYNGENE

SYNGENE share price
SYNGENE earnings valuation
SYNGENE 52-week performance

Profitability Ratios

Profit Margin 7.2%
EBITDA Margin 23.2%
Operating Margin 22.0%
ROE (Annual) 5.7%

Balance Sheet Highlights

Total Assets ₹6,796 Cr
Total Equity ₹4,727 Cr
Current Assets ₹2,287 Cr
Current Liabilities ₹673 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,168 Cr
Investing Cash Flow ₹-744 Cr
Financing Cash Flow ₹-142 Cr
Net Cash Flow ₹281 Cr

Current Market Data

Current Price ₹399.05
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 933
Jun 2025 892
Mar 2025 1,037
Sept 2025 926

Net Profit Trend (₹ Cr)

Dec 2025 15
Jun 2025 87
Mar 2025 183
Sept 2025 67

Operating Margin Trend (%)

Dec 2025 15.0%
Jun 2025 24.0%
Mar 2025 34.0%
Sept 2025 22.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Syngene International quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores